Calumet Specialty Products Partners
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance Brands segments. The Specialty Products and Solutions segment offers various solvents, waxes, custo… Read more
Calumet Specialty Products Partners (CLMT) - Total Liabilities
Latest total liabilities as of September 2025: $3.18 Billion USD
Based on the latest financial reports, Calumet Specialty Products Partners (CLMT) has total liabilities worth $3.18 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Calumet Specialty Products Partners - Total Liabilities Trend (2001–2024)
This chart illustrates how Calumet Specialty Products Partners's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Calumet Specialty Products Partners Competitors by Total Liabilities
The table below lists competitors of Calumet Specialty Products Partners ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Quaker Chemical Corporation
NYSE:KWR
|
USA | $1.45 Billion |
|
HUTCHMED (China) Limited
PINK:HMDCF
|
USA | $501.83 Million |
|
Linktel Technologies Co. Ltd. A
SHE:301205
|
China | CN¥1.17 Billion |
|
HEXPOL AB ser. B
LSE:0R7O
|
UK | Skr6.31 Billion |
|
Manappuram Finance Limited
NSE:MANAPPURAM
|
India | ₹389.37 Billion |
|
Hunan Zhongke Electric
SHE:300035
|
China | CN¥8.56 Billion |
|
Mednax Inc
NYSE:MD
|
USA | $1.31 Billion |
|
Turning Point Brands Inc
NYSE:TPB
|
USA | $391.77 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down Calumet Specialty Products Partners's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Calumet Specialty Products Partners's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Calumet Specialty Products Partners (2001–2024)
The table below shows the annual total liabilities of Calumet Specialty Products Partners from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $3.22 Billion | +7.63% |
| 2023-12-31 | $3.00 Billion | -1.08% |
| 2022-12-31 | $3.03 Billion | +20.52% |
| 2021-12-31 | $2.51 Billion | +29.74% |
| 2020-12-31 | $1.94 Billion | +5.48% |
| 2019-12-31 | $1.84 Billion | -9.18% |
| 2018-12-31 | $2.02 Billion | -21.30% |
| 2017-12-31 | $2.57 Billion | +2.49% |
| 2016-12-31 | $2.51 Billion | +7.08% |
| 2015-12-31 | $2.34 Billion | +1.35% |
| 2014-12-31 | $2.31 Billion | +42.10% |
| 2013-12-31 | $1.63 Billion | +19.22% |
| 2012-12-31 | $1.36 Billion | +35.90% |
| 2011-12-31 | $1.00 Billion | +62.22% |
| 2010-12-31 | $618.39 Million | +13.15% |
| 2009-12-31 | $546.51 Million | -10.09% |
| 2008-12-31 | $607.85 Million | +117.70% |
| 2007-12-31 | $279.21 Million | +84.31% |
| 2006-12-31 | $151.49 Million | -58.00% |
| 2005-12-31 | $360.66 Million | +27.13% |
| 2004-12-31 | $283.69 Million | +49.67% |
| 2003-12-31 | $189.54 Million | +1.39% |
| 2002-12-31 | $186.95 Million | +6.98% |
| 2001-12-31 | $174.76 Million | -- |